PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25022F0015Radiopharm PET RX — Sofie Co

Sofie Co holds $30.8M across 107 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25022D0006. PoP ended Sep 30, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

250-Network Contract Office 10 (36C250)

Awarding office

Sofie Co

Recipient

Sep 30, 2022

PoP end

$278K

Obligated

$1.3M

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Sofie Co — $90

Contract facts

Federal

Contract number36C25022F0015

Also listed as36C250-22-F-0015

Also listed as36C25022D0006-36C25022F0015

Agency250-Network Contract Office 10 (36C250)

Awarding office250-Network Contract Office 10 (36C250)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSofie Co

CAGE09QR8

UEIJV1AHJHGUGG3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36C25022D0006

Place of performanceSTERLING VA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 1, 2021

PoP end (current)Sep 30, 2022

PoP end (w/ options)Sep 30, 2026

Obligated$278K

Current value$278K

Potential value$1.3M

RADIOPHARM PET RX is a federal award for 250-Network Contract Office 10 (36C250) held by Sofie Co. Estimated value $1.3M ($278K obligated). Current period of performance ends Sep 30, 2022 (potential Sep 30, 2026). Place of performance: STERLING VA.

Recompete timing

Public

● Past PoP end (1422 days ago)

Current PoP ended Sep 30, 2022 (1422 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Sofie Co — $30.8M obligated across 107 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($30.8M) · all agencies

Department of Veterans Affairs (VA)$27.8M · 90%Department of Defense (DOD)$2.9M · 9%

Open full company profile →

Related awards

Same parent · incumbent

36C25525N0412

F18 PROSTATE-SPECIFIC MEMBRANE AGENT (PSMA) - OPTION YEAR 3

$217K

Aug 31, 2026

36C25026N0023

EXERCISING THE ORDERING PERIOD 5

$2.0M

Sep 30, 2026

36C25025F0011

ORDERING PERIOD 4 FOR OY25

$1.6M

Sep 30, 2026

36C25625N0859

PYLARIFY PIFLUFOLASTAT F18

$1.2M

Sep 30, 2026

36C25023N0051

TO EXERCISE ORDERING PERIOD 2. THE ADDITION OF CU 64 DOSES TO RADIOPHARM PET RX

$872K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25022F0015?

36C25022F0015 (Radiopharm PET RX) is a 250-Network Contract Office 10 (36C250) award with a potential value of $1.3M, currently held by Sofie Co. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-22-F-0015?

36C250-22-F-0015 is the dashed form of PIID 36C25022F0015 (Radiopharm PET RX), held by Sofie Co. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25022F0015?

250-Network Contract Office 10 (36C250) awarded 36C25022F0015 to Sofie Co (potential $1.3M).

Who is the incumbent on 36C25022F0015?

Sofie Co is the incumbent with $30.8M across 107 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.

When does Sofie Co’s 36C25022F0015 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action Nov 22, 2022